科力遠(600478.SH):預計二季度在碳酸鋰滷水業務正常生產的前提下,業績將會有較好表現
格隆匯5月16日丨科力遠(600478.SH)於2023年5月12日接受機構調研,來訪投資者首先參觀了公司HEV用極片和鎳氫電池製造車間,對公司智能製造能力、精益管理水平和工匠精神表示讚許。互動交流中,就“公司碳酸鋰達產後為公司貢獻業績會提升毛利率,今年二季度業績會增長嗎?”,公司回覆稱,公司碳酸鋰資源優先保障產業創新聯合體以及公司儲能業務對於原材料的需求。目前碳酸鋰價格快速回暖,對上游材料行業是一個利好。預計二季度在碳酸鋰滷水業務正常生產的前提下,業績將會有較好表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.